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The field of angiogenesis research has primarily focused on the mechanisms of sprouting angiogenesis. Yet
vascular networks formed by vessel sprouting subsequently undergo extensive vascular remodeling to form
a functional and mature vasculature. This ‘‘trimming’’ includes distinct processes of vascular pruning, the
regression of selected vascular branches. In some situations complete vascular networks may undergo
physiological regression. Vessel regression is an understudied yet emerging field of research. This review
summarizes the state-of-the-art of vessel pruning and regression with a focus on the cellular processes
and the molecular regulators of vessel maintenance and regression.Introduction
A PubMed search for the term ‘‘angiogenesis’’ (June 2015)
yields almost 80,000 hits. Conversely, a screen for ‘‘VEGF’’ or
‘‘vascular endothelial growth factor’’ identifies 71,000 publica-
tions. This comparison illustrates that the history of the field of
angiogenesis research is also the history of VEGF research,
with the majority of the angiogenesis literature focusing one
way or the other on aspects of VEGF biology. VEGF stands
high up in the hierarchy of events that leads to the formation of
new blood vessels. It is very much compatible with the tip cell
concept of invading angiogenic endothelial cells (ECs) that follow
a VEGF gradient to establish novel capillary sprouts (Gerhardt
et al., 2003; Potente et al., 2011). The role of VEGF as master
switch of angiogenesis induction has made VEGF an attractive
target of therapeutic intervention, most notably in the context
of oncology as well as in ophthalmology (Carmeliet and Jain
2011).
The focus on VEGF has overshadowed the fact that it takes
more than a vascular sprout to grow a hierarchically structured,
mature, three-dimensional vascular network. Guided by the
need to improve VEGF-targeting therapies, the focus of the field
of angiogenesis research has in recent years shifted toward the
analysis of network formation mechanisms as well as the study
of vessel maturation and remodeling processes. This has led
to the discovery of vascular guidance and networking molecules
as well as the identification of vessel maturation-regulating mol-
ecules such as the angiopoietins (ANG) and the PDGFs (Potente
et al., 2011).
When dissecting vessel maturation and remodeling, one can
conceptually think of different growth patterns leading to the
formation of a vascular network (Figure 1). First, it could be
assumed that angiogenesis and vessel maturation are linear pro-
cesses that start with a sprout and proceed gradually over time
(Figure 1A, dotted line). Thismay be unlikely, considering that na-
ture’s mechanisms usually follow as endpoint equilibration reac-
tions inverse exponential curves, i.e., it is more likely to assume
that angiogenesis is initially a rapid process that continues over
time with decelerating pace to eventually reach an equilibrium(Figure 1A, red line). Alternatively, triggered by metabolic de-
mands and strong inductive forces, angiogenesis could proceed
as an overshooting reaction that leads to the formation of more
than necessary blood vessels. Excessive blood vessels would
regress over time in a declining rather than an accelerating equi-
librium reaction (Figure 1A, black line).
Critically assessing the above-listed three theoretical sce-
narios, it is all too obvious that angiogenesis in vivo follows the
black line of Figure 1A. The intensely studied postnatal mouse
retinal vascular network may be the best example for this
pattern: vessel density at the sprouting front of a postnatal retina
(P2–P8) is substantially higher than in themature, fully remodeled
vascular network of the adult retina (Figure 1A). This trimming of
a vascular network is called ‘‘vessel pruning’’ and marks the
physiological regression of a subset of microvessels within a
growing vasculature.
Beyond vessel pruning, vascular networks may also physio-
logically undergo complete regression. It occurs, for example,
developmentally during the regression of hyaloid vessels (Ito
and Yoshioka, 1999) and in the adult during luteolysis
(Figure 1B). Luteolysis marks the rapid dissociation of themature
ovarian corpus luteum at the end of the ovarian cycle. Triggered
by the downregulation of VEGF and the upregulation of ANG2,
the extensive vascular network of the corpus luteum completely
dissociates within a few days and gradually resolves into scar tis-
sue over a period of weeks (Goede et al., 1998; Modlich et al.,
1996). This prominent example illustrates that nature has
secured mechanisms and pathways for the controlled dissocia-
tion of established vascular networks. It also highlights that
vessel regression may be triggered by the shut-off of ON signals
(e.g., VEGF) as well as the active engagement of OFF signals
(e.g., ANG2).
Adapting the concepts of vessel pruning and regression to tu-
mors has important conceptual and therapeutic implications.
Tumor growth proceeds unidirectionally, i.e., tumors keep
growing and the tumor vasculature expands correspondingly
following the induction of the angiogenic switch. As such, spon-
taneous regression does not occur and the vasculature growsDevelopmental Cell 34, July 6, 2015 ª2015 Elsevier Inc. 5
Figure 1. Concepts of Angiogenesis and Vessel Regression as
Dynamic Processes
(A) A growing vascular network could expand over time in a linear fashion
(dotted line). Alternatively, angiogenesis could follow an inverse exponential
growth curve, with rapid initial growth and later decelerating growth (red line).
Third, angiogenesis could proceed as an overshooting reaction followed by
the pruning of excessive vessels (black line). The postnatal retinal angiogen-
esis model (inserts) may be the best example for such a growth pattern,
demonstrating that physiological angiogenesis is associated with distinct
processes of vessel pruning.
(B) Mature vascular networks may undergo complete vascular regression. In
the ovary, growth and regression of the cyclic corpus luteum is associatedwith
distinct phases of angiogenesis, vessel maturation, and vessel regression.
Luteolysis leads to the physiologically triggered massive destruction of the
entire corpus luteum vasculature.
(C) Without therapeutic interference, tumor growth and associated angio-
genesis proceed after the angiogenic switch unidirectionally toward progres-
sion. Anti-angiogenic intervention was originally pioneered as angioregressive
therapy. In clinical reality, anti-angiogenic tumor therapy is partially effective.
The pruning of the most immature tumor-associated vasculature has been
termed ‘‘normalization.’’
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inal goal of anti-angiogenic intervention was to starve tumors to
death by driving the tumor-associated vasculature into regres-
sion (Folkman, 1971). While this may be achieved in some pre-
clinical tumor models, clinical reality has shown that this does6 Developmental Cell 34, July 6, 2015 ª2015 Elsevier Inc.not occur in human tumors. Instead, anti-angiogenic therapies
targeting the VEGF/VEGFR pathway prune the most immature
vasculature and leave behind a more normal-appearing network
of mature vessels (Carmeliet and Jain, 2011). This process has
been called ‘‘vascular normalization’’ and is at the heart of mech-
anistically explaining the synergistic effects of anti-angiogenic
therapy and chemotherapy. Further improvement of the thera-
peutic efficacy of established anti-angiogenic intervention will
require a better understanding of vessel pruning and regression
(Figure 1C).
Learning from developmental biology settings, this review is
aimed at discussing the state of the art of vessel pruning and
regression research. We will review vessel pruning and regres-
sion in different physiological processes and discuss the cellular
mechanisms and molecular mediators of regressive vessel re-
modeling and vessel maintenance.
Vessel Pruning and Regression in Different
Physiological Processes
Vessel remodeling leading to pruning and regression has been
studied in embryonic and postnatal development of mouse
(Franco et al., 2015; Korn et al., 2014; Rao et al., 2007; Udan
et al., 2013), rat (Hughes and Chang-Ling, 2000), and zebrafish
vasculature (Chen et al., 2012; Kochhan et al., 2013; Lenard
et al., 2015). Regressive vascular remodeling also occurs during
adult reactivation of quiescent vessels such as during corpus lu-
teum regression (Modlich et al., 1996) and upon therapeutic
VEGF manipulation (Baffert et al., 2006; Inai et al., 2004). In
mouse embryonic development, vascular remodeling is critical
for patterning of most vascular beds after primitive vascular
plexus formation between E10.5 and E12.5. Mice with genetic
inactivation of factors involved in vascular remodeling die during
midgestation, and multiple mutations affecting vascular remod-
eling have been identified so far (Potente et al., 2011).
During postnatal development, retinal and hyaloid vascular
beds undergo extensive hydrostatically coupled vessel regres-
sion. In the mouse retina, vessel sprouting starts radially from
the center at postnatal (P) day 1, reaching the periphery around
P7 (Fruttiger, 2007). In this system, vessel regression starts when
sprouting angiogenesis is still ongoing in the outer layers at P5
and continues until P18. Immature vessels in the inner plexus
regress, and capillary-free zones around the major vessels
develop. Yet regressing vessels are also detected at the
advancing vascular front, demonstrating that vascular remodel-
ing is not completely spatially restricted (Franco et al., 2015;
Fruttiger, 2007; Korn et al., 2014). Prior to vascularization, the
retina is nourished by the pupillary membrane vessels and the
hyaloid vasculature. These capillary networks are only transiently
present and gradually regress after birth (Ito and Yoshioka, 1999;
Poche´ et al., 2015). Poor retina vascularization resulting in low
oxygenation and high VEGF-A levels often cause hyaloid vessel
persistence, demonstrating the interdependence of the two
vascular networks (Claxton and Fruttiger, 2003; Rao et al., 2007).
During the adult ovarian cycle, growth and regression of the
corpus luteum is accompanied by sprouting and regression of
blood vessels. Vessel constriction and occlusion are followed
by rounding and detachment of single EC and EC sheets from
the extracellular matrix and subsequent shedding into the circu-
lation (Goede et al., 1998; Modlich et al., 1996). During
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increases by sprouting angiogenesis and intussusception.
Conversely, involution of the breast endothelium after lactation
is accompanied by gradual regression of the newly formed capil-
lary plexuses (Andres andDjonov, 2010). Thus, vessel regression
is a prevalent process required for vessel patterning in multiple
organs at different developmental stages and for maintaining
of the dynamic nature of some vascular beds throughout life.
Apoptosis and Migration as Drivers of Vessel Pruning
and Regression
The initial triggers selecting particular branches for vessel
regression as well as the fate of regressing ECs are largely un-
known. It is an open debate if vessel regression is stimulated
by active signaling pathways or if it results from the withdrawal
of survival factors or a combination of both. In particular, the
contribution of EC apoptosis to regressive vessel remodeling is
controversial and likely depends on the context of different
vascular beds.
Under some conditions, EC apoptosis may be the primary
mechanism triggering vessel regression due to the withdrawal
of survival factors such as VEGF (Alon et al., 1995; Baffert
et al., 2006; Benjamin et al., 1999; Inai et al., 2004; Meeson
et al., 1999). Likewise, in situations of drastically changing meta-
bolic demands, such as during involution of the lactating breast
(Andres and Djonov, 2010), therapeutic tumor targeting
(Benjamin et al., 1999; Inai et al., 2004), or loss of entire vascular
plexuses (Lang et al., 1994; Lobov et al., 2005; Meeson et al.,
1996), the vasculature undergoes complete regression involving
massive EC apoptosis.
During pupillary membrane vessel regression, macrophages
induce a first wave of initiating apoptosis in single EC. Subse-
quent lumen constriction and flow stasis induce a second phase
of synchronous EC apoptosis in which whole vessel segments
undergo programmed cell death (Lang et al., 1994; Meeson
et al., 1996, 1999). Regression of hyaloid vessels also involves
EC apoptosis and subsequent EC clearance by macrophages
and/or shedding into the vascular lumen (Mitchell et al., 1998).
During mammary gland involution, EC apoptosis partially ac-
counts for vascular regression and peaks together with maximal
vessel occlusion (Andres and Djonov, 2010). Moreover, O2-
induced vessel regression in retinopathy of prematurity (ROP)
models depends on selective EC apoptosis (Alon et al., 1995).
While the contribution of EC apoptosis to vessel regression in
the above-listed biological processes is largely undisputed, se-
lective pruning of only a subset of vessels might involve different
processes in different situations. In this case, EC apoptosis may
not be the primary trigger of regression, but could rather be a
secondary effect of impaired blood flow-mediated reduced sur-
vival signaling in pruning segments. Disintegration of EC from the
vascular network as consequence of ECmigration away from the
regression fragment and subsequent dissociation from the basal
lamina could also lead to EC apoptosis (Dimmeler and Zeiher,
2000; Wietecha et al., 2013). Along these lines, increased EC
apoptosis has been correlated with reduced EC numbers and
enhanced vessel regression in the postnatal retina upon deletion
of the WNT secretion factor Evi/Wls in EC (Korn et al., 2014).
Apoptosis-related retinal vessel regression was also observed
upon endothelial deletion of the rho guanine exchange factor(GEF) FYVE, RhoGEF, and PH domain containing 5 (Fgd5)
(Cheng et al., 2012; Korn and Augustin, 2012). Thus, if pruning
results in a compromised circulation requiring elimination
of excessive EC to match tissue needs, EC apoptosis may
contribute to regressive vessel remodeling. A study in the zebra-
fish eye suggests that vessel regression involves all three pro-
cesses of EC migration, re-deployment, as well as apoptosis.
Vessel pruning was triggered in response to low blood flow,
and ECs either migrated to neighboring branches in which
they were incorporated or died by macrophage-independent
apoptosis (Kochhan et al., 2013).
A number of studies explain vessel regression independent of
EC apoptosis solely as a consequence of EC migration. Live-cell
imaging of the vasculature in zebrafish midbrain and cultured
mouse embryos suggested that remodeling of redundant loop-
forming or parallel vessel segments is independent of apoptosis.
In these systems, pruning depends on blood flow-controlled
lateral ECmigration and subsequent integration into neighboring
vessels (Chen et al., 2012; Udan et al., 2013). During vessel
remodeling in the mouse embryo, EC migration is followed
by fusion of neighboring vessels causing a rapid decrease
in vascular complexity and an increase in vessel diameter. The
combination of EC migration and fusion is particularly important
for shaping the hierarchically ramified arterial tree (Udan et al.,
2013).
Recycling of ECs during vessel regression is also observed in
the chicken yolk sac, in which vessels disconnecting from the vi-
telline arteries are re-used for establishing novel vessel connec-
tions (le Noble et al., 2004). In the postnatal rat retina, vessel
retraction has been shown to involve EC rounding, migration,
and subsequent redeployment in new vessels in the immediate
vicinity. The localization of regressing branches in the periphery
of the retina close to growing vessels supports an EC recycling
concept. Moreover, only few apoptotic ECs were detected in
the inner plexus of the retina, and numbers did not increase
with empty basement membrane sleeves (ebms) accumulating
during the second postnatal week. Neither apoptotic ECs nor
macrophages were enriched close to regressing vessel seg-
ments, favoring a process of apoptosis-independent vessel
regression (Hughes and Chang-Ling, 2000). However, the pres-
ently used static models do not allow correlation of these kinet-
ically different processes, considering that cleaved caspase
3-positive or TUNEL-positive ECs have a short half-life time,
whereas ebms may persist for 2–3 weeks during trachea and tu-
mor vessel regression (Baffert et al., 2006; Inai et al., 2004). Like-
wise, apoptotic ECs would not be expected close to ebms, if EC
apoptosis was a consequence of disintegration of the retracting
ECs from the regressing vessel. The commonly observed shed-
ding of apoptotic ECs into the vascular lumen and/or their clear-
ance by macrophages further complicates the detection of
apoptotic ECs. As the present understanding of vessel remodel-
ing is integrated from studies in wild-type and mutant animals,
caution should be taken by comparing physiological and patho-
logical vessel remodeling, which might follow different path-
ways.
Higher-resolution studies that apply novel technologies allow-
ing dynamic visualization of EC apoptosis and vessel regression
are only beginning to emerge. Two recently published studies
shed substantially higher-resolution insights into the dynamicsDevelopmental Cell 34, July 6, 2015 ª2015 Elsevier Inc. 7
Figure 2. Multistep Nature of Vessel Pruning and Regression
Processes
(A–D) Following the primarily blood flow-driven selection of a branch for
regression (A), the vessel constricts (B) until it occludes (C) and the blood flow
ceases (D). ECs in regressing vessel segments may retract and undergo
apoptosis (1), or they may migrate away to re-integrate elsewhere (2), leaving
behind ColIV+ empty basement membrane sleeves (ebms). Retracting ECs
might disintegrate from the vascular network and undergo EC apoptosis due to
detachment from the basement membrane (3).
(E) In a final resolution step, regression of the selected branch is completed,
leaving a remodeled vascular network behind.
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clearly advancing the cellular understanding of the remodeling
process. Franco and co-workers have analyzed vascular pruning8 Developmental Cell 34, July 6, 2015 ª2015 Elsevier Inc.in the postnatal mouse retinal vasculature and propose a four-
step model for vessel regression (Figure 2) consisting of branch
selection (Figure 2A), lumen stenosis (Figures 2B and 2C), EC
retraction (Figure 2D), and resolution (Figure 2E) (Franco et al.,
2015). High-resolution imaging of the retina demonstrated that
physiological microvessel regression may occur independent
of apoptosis involving flow-induced EC rearrangement and
retraction from the regressing branch and EC redeployment in
the remaining vasculature (Franco et al., 2015). A second high-
resolution and spatiotemporal study of developmental vessel
pruning has established the subintestinal vein (SIV) plexus of
the zebrafish embryo as novel model to study vessel pruning
at the cellular level (Lenard et al., 2015). Developing novel live-
cell imaging techniques for analyzing vessel remodeling is
essential to improve quantification of vascular regression at the
cellular level. Despite the refinement of immunostaining tech-
niques and development of high-resolution imaging in the last
years, the present static methods are limited, explaining why
vessel remodeling is still an understudied field. Lenard and co-
workers describe vessel remodeling as vessel anastomosis in
a reversed order independent of EC apoptosis. This process in-
volves cell-cell contact resolution and lumen collapse, as well as
EC migration toward opposing sides and subsequent EC fusion
with the parental branch. Before complete separation of ECs
from the parental vessel, the vascular lumen breaks and recon-
nects multiple times (Lenard et al., 2015). Taken together, prun-
ing and trimming of vascular beds during developmental regres-
sive vessel remodeling may result from a combination of EC
migration, redeployment, and apoptosis, whereas vessel regres-
sion during complete vascular plexus resolution is primarily
driven by EC apoptosis.
The Contribution of Blood Flow to Vessel Pruning and
Regression
Non-perfused vessels are predisposed to vascular pruning, and
changes in blood flow act as regulators of vessel regression (Fig-
ures 2B and 2C) (Ando and Yamamoto, 2009). It has already
been proposed more than a century ago that the vessels with
the highest blood flow enlarge and those carrying the least blood
flow regress (Thoma, 1893). Several follow-up studies confirmed
the importance of hemodynamic forces for vascular remodeling
in zebrafish (Chen et al., 2012; Kochhan et al., 2013; Lenard et al.,
2015), chicken (le Noble et al., 2004), rabbit (Langille et al., 1989),
and mouse (Franco et al., 2015; Garcia and Larina, 2014; Lucitti
et al., 2007; Udan et al., 2013). Along these lines, remodeling of
the primitive vascular plexus during embryogenesis is initiated
after establishment of the first heartbeat and onset of blood
flow (Garcia and Larina, 2014; Lucitti et al., 2007). Several mouse
mutants with disrupted heart function and impaired blood flow
are embryonic lethal due to impaired vascular remodeling of
the yolk sac, further stressing the importance of hemodynamic
forces for vascular remodeling (Huang et al., 2003).
Pharmacological induction of vasoconstriction or vessel
obstruction induced pruning in zebrafish and mouse retina,
whereas stimulation of blood flow protected branches from
regression (Chen et al., 2012; Kochhan et al., 2013; Lobov
et al., 2011). Similarly, pharmacological inhibition of vasocon-
striction or induction of vessel dilation reduced blood vessel sta-
bility in the mouse retina, indicating that vessel pruning is
Figure 3. Signaling Pathways Controlling
Vessel Pruning and Regression
Multiple signaling pathways have been identified
as regulators of vessel regression. VEGF/VEGFR2
signaling, non-canonical WNT signaling, and
blood flow-induced signaling serve as critical
maintenance factors of the vasculature that are
involved in the control of vessel regression.
Canonical WNT signaling stabilizes the vascular
network and promotes EC proliferation. DLL4/
Notch signaling supports vessel regression by
promoting vessel constriction and flow stasis. The
outcome of ANG/TIE signaling during vessel re-
modeling is context dependent. Whereas ANG1
supports EC survival, ANG2 destabilizes the
vascular network, driving it into regression in the
absence of survival factor activity (e.g., VEGF).
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not clear if mechanical factors like shear stress and circumferen-
tial stretch or molecular components such as oxygen or angio-
genic factors are the primary mediators of flow-controlled vessel
regression (Culver and Dickinson, 2010).
The mechanical forces of blood flow are necessary and suffi-
cient for yolk sac remodeling as embryos with a low hematocrit
showed impaired capillary plexus remodeling and downregula-
tion of the mechanosensitive factor eNOS, which could be
rescued by restoring blood viscosity (Lucitti et al., 2007). Simi-
larly, micewith disturbed hematopoiesis leading to low blood he-
matocrit were characterized by vascular remodeling defects (He
et al., 2008). Hemodynamic forces are particularly important for
shaping the arterial tree and during aortic arch remodeling
(Buschmann et al., 2010; Yashiro et al., 2007).
Blood flow triggers several downstream effects, which can all
contribute to vessel regression, including vessel constriction, EC
survival, alignment, and migration (Figure 3) (Chen et al., 2012;
Franco et al., 2015; Kochhan et al., 2013; Lenard et al., 2015;
Meeson et al., 1996; Udan et al., 2013). Shear stress induces
AKT signaling, resulting in Kru¨ppel-like factor 2 (KLF2) activation
and subsequent upregulation of nitric oxide (NO)-synthase and
superoxide dismutase, thereby promoting EC survival and NO-
mediated vessel dilation (Dekker et al., 2005; Dimmeler and
Zeiher, 2000). Shear stress-induced survival signaling has also
been observed in the pupillary membrane, the corpus luteum,
and the trachea as flow stasis resulting from vessel occlusion
led to rapid vessel regression (Azmi and O’Shea, 1984; Baluk
et al., 2004; Meeson et al., 1996). Shear stress reduction alsoDevelopmentalstimulates expression of vasoconstric-
tors, and vasoactive proteins are regu-
lated during retinal vessel regression,
conferring a constrictive phenotype (Lo-
bov et al., 2011; Morawietz et al., 2000).
Blood flow controls directed EC migra-
tion away from the regressing vessel and
subsequent EC incorporation into the
remaining vasculature (Chen et al.,
2012; Franco et al., 2015; Kochhan
et al., 2013; Lenard et al., 2015; Udan
et al., 2013). In quiescent arteries and
veins, ECs align against the flow, asshown by high-resolution imaging of EC nuclei and Golgi in the
postnatal retina (Franco et al., 2015). Differential flow patterns
in juxtaposed vessels trigger developmental vessel regression
by breaking EC symmetry, resulting in EC retraction from
low-flow branches and subsequent incorporation into high-
flow segments (Chen et al., 2012; Franco et al., 2015; Kochhan
et al., 2013; Lenard et al., 2015). Time-lapsemicroscopy analysis
of cultured mouse embryos similarly revealed directed EC
migration from low-flow to high- and pulsatile-flow vessels
(Udan et al., 2013). The direction of flow-induced polarized EC
migration during vessel regression is determined by the axial
polarity between EC Golgi and nucleus (Franco et al., 2015). In
the zebrafish midbrain, flow-regulated EC migration is Rac
dependent and involves subsequent EC integration in the re-
maining vasculature (Chen et al., 2012). Similarly, flow is sensed
by EC in the zebrafish eye and controls EC rearrangements,
migration, and apoptosis, resulting in pruning of low-flow vessels
(Kochhan et al., 2013).
The presence or absence of flow has also been shown to
determine the mode of pruning and particularly the sequence
of lumen collapse and EC rearrangements. Lumen collapse ad-
vances EC rearrangements during type I pruning in the absence
of flow. These cell rearrangements lead to the formation of a uni-
cellular connection, which subsequently resolves via regression
of the last linking cell. In contrast, type II pruning starts in
perfused vessels with EC rearrangements, and the lumen is
maintained until the last EC forms a transcellular lumen that
eventually collapses via self-fusion to form two separate luminal
compartments (Lenard et al., 2015). In conclusion, blood flow isCell 34, July 6, 2015 ª2015 Elsevier Inc. 9
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regressive vessel remodeling.
Regulation of Vessel Pruning and Regression by
Oxygenation and VEGF Signaling
Similar to sprouting angiogenesis, vessel regression is controlled
by tissue oxygenation.Wide capillary-free spaces surround large
O2-rich blood-carrying retinal arteries (Claxton and Fruttiger,
2003). Hyperoxia leads to VEGF downregulation, causing
massive obliteration of central retinal capillaries (Alon et al.,
1995; Claxton and Fruttiger, 2003). Along these lines, astro-
cyte-specific VEGF deletion resulted in massive vessel regres-
sion in the retina in response to hyperoxia (Scott et al., 2010).
However, VEGF does not completely rescue hyperoxia-induced
vessel regression, and other pathways activated by FGF2,
ANG2, PDGF, and DLL4 have been described to control
VEGF-independent vessel stabilization (Augustin et al., 2009;
Hou et al., 2010; Lieu et al., 2011; Lobov et al., 2011). In contrast,
hypoxia incubation of pups as well as intravitreal VEGF injection
interfered with retinal vessel regression by inducing endothelial
phosphoinositide 3-kinase (PI3K)/AKT survival signaling. High
O2 levels following primary plexus formation lead to reduced
VEGF levels, thereby inducing EC apoptosis and vessel regres-
sion (Figure 3) (Alon et al., 1995; Baffert et al., 2006; Claxton
and Fruttiger, 2003).
The involvement of VEGF signaling in vascular regression has
also been studied in the trachea angiogenesis model aswell as in
Lewis lung carcinoma (LLC), rat insulin promoter-SV40 large
T-antigen 2 (RIP-Tag2), and xenograft tumor models. Inhibition
of VEGF-A signaling in these models or withdrawal of VEGF-A
overexpression stimulated vessel regression by promoting
cessation of blood flow and EC apoptosis (Baffert et al., 2006;
Baluk et al., 2004; Benjamin et al., 1999; Inai et al., 2004).
Whereas the surviving vessels were VEGF independent with little
branching and uniform caliber, dying VEGF-dependent ECs de-
tached from their basement membrane. The remaining ebms
served as scaffolds for vascular regrowth after termination of
treatment. In RIP-Tag2 and LLC tumor models, two subsequent
courses of VEGF inhibition resulted in two rounds of vascular
regression and regrowth along the ebms, demonstrating the
plasticity of the regression process (Baffert et al., 2006; Inai
et al., 2004; Mancuso et al., 2006).
Repetitive rounds of vessel formation and regression have
also been observed in the corpus luteum and during the mam-
mary gland reproductive cycle, which are paralleled by increases
and decreases of VEGF production (Modlich et al., 1996). Hya-
loid and pupillary membrane vessel (PM) stability also depends
on VEGF-mediated survival signaling. Notably, the second
phase of synchronous apoptosis during PM vessel regression
results from the lack of VEGF in non-perfused and constricted
vessels (Meeson et al., 1999; Mitchell et al., 1998). In conclusion,
high O2-tension-controlled VEGF downregulation promotes EC
apoptosis, thereby inducing vessel regression and formation of
ebms, which may serve as scaffold for vascular regrowth.
WNT and Notch Signaling Decide Whether to ‘‘Make or
Break a Vessel’’
Beyond VEGF, Notch and WNT signaling orchestrate vessel
pruning and regression (Figure 3) (Korn et al., 2014; Lobov10 Developmental Cell 34, July 6, 2015 ª2015 Elsevier Inc.et al., 2011; Phng et al., 2009). WNT ligands signal via Frizzled
(FZD) receptors to regulate EC fate determination, migration,
proliferation, and survival by activating canonical and non-
canonical downstream cascades, including planar cell polarity
(PCP) and WNT/Ca2+ signaling (Clevers and Nusse, 2012).
Developmental vascular remodeling critically depends on
precisely controlled levels of canonical WNT signaling, as over-
expression as well as loss of endothelial b-catenin cause embry-
onic lethality around E12.5 (Cattelino et al., 2003; Corada et al.,
2010). Deletion of several other WNT signaling components
including Wnt2, Wnt4, Fzd4, Fzd5, Rspo3, and Wnt7b similarly
resulted in reduced embryonic and extraembryonic vasculariza-
tion, often correlating with remodeling defects (Ishikawa et al.,
2001; Kazanskaya et al., 2008; Monkley et al., 1996; Shu et al.,
2002).
WNT/b-catenin signaling is also critical to stabilize postnatal
retinal vessels, as loss of endothelial b-catenin or Lef1 reduces
retinal vessel density, interferes with stalk cell proliferation, and
induces premature vessel regression (Phng et al., 2009). Like-
wise, the EC transcription factor ERG transactivates Fzd4 and
Cdh5 expression to induceWNT/b-catenin signaling, supporting
EC proliferation and survival (Birdsey et al., 2015). Canonical
WNT signaling-dependent retinal vessel stabilization can also
occur independent of WNT ligands via Norrin and TSPAN12-
induced FZD4/LRP5 complex clustering. Along these lines,
several WNT signaling mutants including endothelial FZD4-,
LRP5-, NDP-, and TSPAN12-deficient mice are characterized
by the absence or reduced density of intraretinal and inner ear
vessels (Ye et al., 2010).
Besides the canonical WNT signaling pathway, EC-derived
non-canonical WNT ligands control vessel pruning and regres-
sion by stimulating EC survival and proliferation. Endothelial
deletion of the WNT secretion factor Evi/Wls resulted in
increased retinal vessel regression. Reduced EC proliferation
and increased EC apoptosis correlated with Stat2 and Cdkn1a
up- and Tie2 downregulation (Korn et al., 2014). Non-canonical
WNT ligand-induced Tie2 expression was also important for sur-
vival signaling in cultured ECs and promoted pulmonary vessel
stabilization in vivo (Cornett et al., 2013; Masckaucha´n et al.,
2006). The reduced Matrigel plug vascularization in endothelial
Evi/Wls-deleted mice was rescued by introducing non-canonical
WNT5A, further supporting a role for non-canonical WNT ligands
in blood vessel stabilization (Korn et al., 2014).
Shear stress and non-canonical WNT signaling intersect in
the regulation of EC survival and cell polarity (Cirone et al.,
2008; Lizama and Zovein, 2013). During lymphatic valve remod-
eling, shear stress enhances nuclear factor of activated T cells
(NFAT) signaling in lymphatic ECs, and NFATc3/NFATc4-
and calcineurinB-deficient mice are embryonic lethal due to
disturbed vessel remodeling (Graef et al., 2001; Sabine et al.,
2012). Shear stress also upregulates NFAT target genes in EC
and increases endothelial Ca2+/CaMKII/eNOS signaling (Nauli
et al., 2008; Topper et al., 1996). Moreover, shear stress-sensi-
tive Ca2+-channels control downstream ERK/eNOS signaling,
and mice lacking these channels are characterized by remodel-
ing defects (Ando and Yamamoto, 2013). Shear stress has also
been proposed as upstream regulator of endothelial PCP
signaling, controlling microtubule and actin organization to pro-
mote EC alignment and division relative to the direction of flow
Figure 4. Role of Bystander Cells in Vessel
Pruning and Regression
Macrophages serve as important bystander cells
during vessel regression. During retinal angio-
genesis, myeloid-derived non-canonical Wnt li-
gands WNT5A and WNT11 control EC fate and
vessel branching activating myeloid Ca2+/CN/
NFAT signaling. This stimulates sFLT1 expression,
which sequesters VEGF to inhibit retinal vessel
formation (Stefater et al., 2011). During hyaloid
vessel regression, macrophages may actively
induce EC death in a WNT7B-dependent manner.
Canonical WNT7B signaling stimulates hyaloid EC
cell cycle entry. In the absence of ANG1/TIE2-
mediated AKT/PI3K survival signaling, WNT7B-
stimulated ECs exit the cell cycle and undergo
apoptosis, resulting in hyaloid vessel regression.
In contrast to ECs, which provide ANG2 for vessel
destabilization, pericytes provide ANG1 to stabi-
lize the vasculature. However, whether pericytes
detach from regressing vessels or stay attached to
the empty basement membrane sleeves of re-
gressing branches is not studied in detail. Leuko-
cytes and in particular cytotoxic T cells may also
induce EC apoptosis.
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components are upregulated during idiopathic pulmonary
arterial hypertension (IPAH), which is characterized by vasocon-
striction, increased blood flow, and loss of immature vessels
(Laumanns et al., 2009). FZD4/PCP signaling is also pivotal for
organization and stabilization of the distal small artery network
in mouse heart and kidney (Descamps et al., 2012).
In contrast to intraretinal and embryonic vessels, WNT
signaling promotes regression of the hyaloid vasculature.
ANG2 stimulates macrophage WNT7B production, thereby
driving hyaloid ECs into cell cycle via activation of canonical
WNT signaling. In the absence of ANG1-mediated AKT/PI3K sur-
vival signaling, WNT7B stimulates ECs to exit the cell cycle via
apoptosis, resulting in hyaloid vessel regression (Figure 4) (Rao
et al., 2007). A tight crosstalk between the ANG/TIE and WNT
pathways is also supported by the persistence of hyaloid vessels
in various mouse models lacking WNT or ANG/TIE components
(Gale et al., 2002; Lobov et al., 2005; Rao et al., 2007).
These apparently opposing effects of WNT signaling on retinal
and hyaloid vessels may reflect differences in the microenviron-
ment or in the dynamics of cellular processes. While intraretinal
vessels are committed to grow during postnatal development
(i.e., vascular pruning), hyaloid vessels are programmed to
regress (i.e., bona fide vascular regression). Similarly, radial
glia cells impair vessel regression by interfering with endothelial
WNT/b-catenin signaling, although radial glia-derived WNT7A
and WNT7B support vessel growth early in development (Cor-
ada et al., 2010; Ma et al., 2013; Stenman et al., 2008). As
such, WNT signaling can intriguingly have distinct and even
opposing context-dependent effects at different stages of devel-
opment and/or in different tissues or vascular beds.
Postnatal retinal vessel stabilization critically depends on the
crosstalk of the WNT/b-catenin pathway with the Delta-like 4
(DLL4)/Notch pathway (Benedito and Hellstro¨m, 2013). DLL4/Notch signaling, which controls tip cell selection, also induces
Notch-regulated ankyrin repeat protein (Nrarp) expression to
promote LEF1-dependent canonical WNT signaling and vessel
stabilization. Loss of Nrarp in mice phenocopies the premature
regression phenotype of Lef1- or endothelial b-catenin-deficient
mice, and nrarp knockdown in zebrafish causes abberant
regression of intersegmental vessels. At the same time, NRARP
limits Notch signaling and interferes with p21/Rb-dependent
cell-cycle arrest. The reduced EC proliferation in an endothelial
Nrarp-depleted environment may also trigger vascular remodel-
ing as a more general mechanism to adapt the vascular network
to reduced EC numbers (Phng et al., 2009).
DLL4/Notch signaling stimulates vessel pruning and regres-
sion by shifting the expression of vasoactive genes toward a
vasoconstrictive phenotype, thereby inducing vessel occlusion,
cessation of blood flow, and subsequent EC apoptosis (Lobov
et al., 2007, 2011). In the retina, Notch signaling is particularly
important for vein and perivenous capillary plexus remodeling
(Ehling et al., 2013). In conclusion, the balance of WNT, Notch,
and ANG/TIE signaling seems to balance vessel formation and
regression.
ANG/TIE Signaling Controls Vessel Pruning and
Regression
The ANG/TIE signaling system is a key player of developmental
vessel formation and remodeling and acts as gatekeeper of
quiescence in the adult resting endothelium (Figure 3). ANG1 is
the constitutive ligand of the TIE2 receptor, and ANG1/TIE2
signaling induces PI3K/AKT-dependent EC survival, mural cell
recruitment, and EC quiescence (Augustin et al., 2009). ANG2,
which is mainly produced by ECs, has originally been identified
as autocrine ANG1/TIE2 antagonist disrupting PI3K/AKT survival
signaling, resulting in vessel destabilization and regression (Cao
et al., 2007; Gale et al., 2002). In situations of high ANG2 levels,Developmental Cell 34, July 6, 2015 ª2015 Elsevier Inc. 11
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and at the tip cell front, ANG2 may act as context-dependent
ANG1/TIE2 agonist. Both agonistic and antagonistic functions
of ANG2 are important to maintain vessel plasticity (Daly et al.,
2013; Hashizume et al., 2010; Kim et al., 2000).
Another modulator of the ANG1/TIE2 signaling system is the
orphan receptor TIE1. Tie1-deficient mice have an embryonic-
lethal phenotype characterized by vascular defects around
E13.5–E14.5 (Puri et al., 1995). TIE1 controls endothelial PI3K/
AKT survival signaling in a blood flow-dependent manner and
thereby interferes with regression of the stalk cell vasculature
(Kontos et al., 2002). TIE1 expression is downregulated by
laminar flow and is particularly responsive to acute changes in
shear stress, supporting a role of TIE1 in blood flow-controlled
vessel remodeling (Porat et al., 2004; Woo et al., 2011).
As regulator of EC survival and migration, ANG/TIE signaling
may be critically involved in the control of vascular pruning.
This hypothesis is supported by the midgestational lethal
phenotype of Ang1- and Tie2-deficient mice showing a persist-
ing capillary plexus that fails to remodel (Dumont et al., 1994;
Suri et al., 1996). Conditional deletion of Ang1 in cardiomyo-
cytes phenocopies constitutive Ang1 deletion, suggesting that
ANG1-dependent vessel remodeling requires proper heart
function and may, thus, be blood flow dependent (Jeansson
et al., 2011).
Ang2-deficient mice have a mild vascular phenotype, but
global overexpression of Ang2 phenocopies the effects of
Ang1/Tie2 deletion favoring an antagonistic role of ANG2 in con-
trolling the constitutive ANG1/TIE2 axis during developmental
vessel remodeling (Cao et al., 2007; Gale et al., 2002; Hackett
et al., 2002). Despite the absence of an embryonic vascular
phenotype, Ang2-deficient mice have a reduced and disorga-
nized postnatal retinal vasculature. The lack of intraretinal capil-
laries in Ang2-deficient and similarly Akt gain-of-function mice
correlated with impaired hyaloid vessel regression. In contrast,
AKT inhibition induces EC apoptosis and stimulates hyaloid
vessel regression, which can be rescued by ANG1 injection
(Gale et al., 2002; Hackett et al., 2002; Rao et al., 2007).
ANG2-blocking antibodies increase remodeling of the central
retinal vessels and at the same time reduce sprouting, support-
ing an agonistic as well as antagonistic role of ANG2 during
retinal vessel remodeling (Felcht et al., 2012).
The context-dependent functions of ANG2 can largely be ex-
plained by the VEGF dependency of ANG2 function. ANG2 pro-
motes EC death and capillary regression under VEGF-deprived
conditions (e.g., in the pupillary membrane, in the hyaloid vascu-
lature, and during corpus luteum regression). In the presence of
VEGF, ANG2 supports ECmigration, proliferation, and sprouting
(Gale et al., 2002; Oshima et al., 2004). ANG2 is primarily de-
tected in tissues undergoing vessel remodeling, including ovary,
uterus, and placenta, emphasizing the important role of ANG2
during vessel remodeling (Hackett et al., 2002). In the ovary,
ANG2 exhibits a cyclic expression pattern correlating with waves
of vessel regression during follicle atresia and corpus luteum
regression (Goede et al., 1998). Increased placental vascular re-
modeling during the first trimester of pregnancy is accompanied
by elevated ANG2 levels, and Ang2 overexpression interfered
with collateral vessel growth after hindlimb ischemia (Reiss
et al., 2007). Moreover, ANG2 is implicated in tracheal vessel re-12 Developmental Cell 34, July 6, 2015 ª2015 Elsevier Inc.modeling by interfering with TIE2 activation during chronic
airway inflammation (Tabruyn et al., 2010).
Several regulators of vessel remodeling, including shear stress,
hypoxia, andVEGF,controlAng2 transcription,demonstrating the
extensive crosstalk between the signaling pathways controlling
vascular pruning. For instance, the shear stress-regulated tran-
scription factor KLF2 downregulates Ang2 and upregulates
Tie2, thereby maintaining the quiescent phenotype after comple-
tion of the remodeling process (Augustin et al., 2009). In conclu-
sion, ANG/TIE signaling is a pivotal system for balancing vascular
remodeling and angiogenic vessel formation in a context-depen-
dent manner.
Additional Signaling Pathways Involved in Vessel
Regression
Beyond the established angiogenesis signaling pathways
involving VEGF, ANG/TIE, Notch, and WNT signaling, some
additional mechanisms have been reported to control vessel
pruning and regression. The GEF FGD5 acts as regulator of
vessel regression in the postnatal retina. Endothelial FGD5 in-
duces HEY/p53 signaling and promotes VEGF sequestration
by increasing the VEGFR1/VEGFR2 ratio, resulting in EC
apoptosis and subsequent vessel regression (Cheng et al.,
2012). Moreover, CRIM1, which stimulates autocrine VEGF-A
signaling, stabilizes retinal vessels and interferes with regression
in the postnatal retina (Fan et al., 2014). Vascular regression dur-
ing dermal wound healing involves CXCL10 binding to endothe-
lial CXCR3, resulting in disruption of critical integrin contacts, EC
detachment, and apoptosis (Bodnar et al., 2009). Remodeling of
the extracellular matrix (ECM) is spatiotemporally linked to
vessel regression, as cleavage of EC/ECM integrin contacts
and release of bioactive ECM fragments critically influence EC
survival signaling (Wietecha et al., 2013).
More recently, light has been described as the initial trigger
of apoptosis-dependent hyaloid vessel regression and retinal
vessel growth inhibition. Light stimulation during late gestation
activates intrinsically photosensitive retinal ganglion cells to pro-
duce melanopsin, which reduces the number of retinal neurons,
thereby limiting tissue hypoxia and VEGF production. Reduced
VEGF levels trigger EC apoptosis and suppress retinal vessel
growth (Rao et al., 2013). Along these lines, a higher average
day length during early gestation was associated with a lower
risk for severe ROP (Yang et al., 2013).
The Fate of Pericytes during Vessel Pruning and
Regression
The role of pericytes as stabilizers of maturing vessels is well es-
tablished. Yet their role during vessel regression is rather contro-
versial (Figure 4). It has not been clarified if pericytes stay
attached to ebms, undergo apoptosis, or migrate onto surviving
vessels. Not only their fate but also pericyte-derived signals con-
trolling vessel remodeling have not been identified. Early studies
showed that disruption of endothelial-pericyte associations
during hyperoxia treatment of mice resulted in excessive retinal
vessel regression and abnormal remodeling (Benjamin et al.,
1998). Along these lines, VEGF inhibition-induced vessel regres-
sion primarily affects vessels with reduced pericyte coverage,
supporting a role of pericytes in stabilizing blood vessels
(Benjamin et al., 1999). However, the combination of VEGF
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of tumors to anti-VEGF drugs, suggesting that anti-VEGF-
induced vessel normalization and regression are independent
of pericytes (Nisancioglu et al., 2010). The presence of pericytes
was also not sufficient to interfere with VEGF/VEGFR inhibition-
induced vessel regression in trachea and in LLC and RIP-Tag2
tumor models. Pericytes temporarily persisted in ebms, but the
majority of the pericytes migrated to surviving capillaries and
some underwent apoptosis (Baffert et al., 2006; Baluk et al.,
2004; Inai et al., 2004).
Pericyte apoptosis in the course of vessel regression has also
been observed during regression of the pupillary membrane and
hyaloid vasculature (Taniguchi et al., 1999). In contrast, pericyte
numbers did not change during several rounds of tumor vessel
regression and regrowth. Only the expression of the pericyte
marker aSMA was downregulated during regression and re-
turned to baseline upon vessel regrowth (Mancuso et al.,
2006). Persistence of pericytes along ebms after Sorafenib-
induced tumor vessel regression was also observed in an induc-
ible mouse model of hepatocellular carcinoma (Runge et al.,
2014). Although no changes in the pericyte coverage of remain-
ing vessels were observed under conditions of enhanced retinal
vessel regression, pericytes have recently been reported to stay
attached to ebms of regressed retinal vessels (Franco et al.,
2015; Korn et al., 2014; Phng et al., 2009). Further studies are
required to investigate the fate of pericytes and their active
contribution to vessel regression.
Role of Inflammatory Cells during Vessel Pruning and
Regression
As during sprouting angiogenesis, macrophages are located
close to regressing vessels, where they are believed to play
active as well as passive roles (Baluk et al., 2004; Ito and Yosh-
ioka, 1999). PU.1 mutant mice lacking resident macrophages
have persistent hyaloid and pupillary membrane (PM) vessels,
supporting a role for macrophages in the regression of these
vascular beds (Lobov et al., 2005). Macrophageswere initially re-
ported to trigger EC apoptosis in a cell-cell contact-dependent
manner and mediate the passive clearance of cell debris (Lang
et al., 1994; Meeson et al., 1996; Mitchell et al., 1998). Recently,
PM macrophages were described to phagocytose shed EC
membrane particles long before PM regression is observed,
thereby facilitating the subsequent regression process (Poche´
et al., 2015). Macrophages provide WNT ligands to induce hya-
loid EC apoptosis in an ANG/TIE-dependent manner (Lobov
et al., 2005; Rao et al., 2007). They were also detected next to
regressing retinal vessels and their numbers increased during
ischemic retinopathy (Shen et al., 2007). Anti-VEGF/VEGFR-
induced remodeling of the trachea vasculature involves macro-
phage-mediated passive clearance of apoptotic ECs (Baluk
et al., 2004). Similar to macrophages, leukocytes and cytotoxic
T cells are capable of inducing EC apoptosis during physiolog-
ical and hyperoxia-induced retinal vessel pruning (Ishida et al.,
2003).
Taken together, immune cells such as macrophages and leu-
kocytes are involved in vessel pruning and regression (Figure 4),
but further research is required to establish a more detailed view
of their precise contribution to the different forms of vessel
regression in various vascular beds.Vessel Regression during Tumor Angiogenesis
The tumor vasculature has an abnormal and chaotic structure
characterized by tortuous and leaky vessels that lack hierarchi-
cal organization and arterio-venous identity (Carmeliet and Jain,
2011). Therefore, it is questionable if the tumor vasculature
undergoes organized morphological processes as they occur
during physiological sprouting, maturation, and remodeling.
In particular, the process of vessel remodeling involving
complex morphological rearrangements and regulation by a
plethora of different factors may be abnormal in the tumor
vasculature. For instance, blood flow, an important regulator
of physiological vessel remodeling, is irregular and compro-
mised in the tumor due to the tortuous and leaky vessel organi-
zation. Moreover, signaling mediators involved in the control of
vessel formation and remodeling including VEGF and ANG2
are upregulated in the tumor environment and, thus, might rather
promote chaotic vessel growth (Carmeliet and Jain, 2011;
Gerald et al., 2013).
Anti-angiogenic tumor therapy was originally pioneered
with the aim to starve tumors to death by stimulating massive
tumor vessel regression (Folkman, 1971). Anti-VEGF/VEGFR
treatments target immature vessels for EC apoptosis-depen-
dent regression. At the same time, such treatments induce
vessel normalization and stabilize mature VEGF-resistant
vessels, thereby improving tumor perfusion and facilitating
chemotherapy (Carmeliet and Jain, 2011). As in physiological
remodeling processes, anti-angiogenic targeting most likely
involves vessel remodeling as consequence of EC apoptosis
(regression), but also as result of EC rearrangements and
migration (normalization).
Ongoing research is aimed at improving the hitherto limited ef-
ficacy of anti-angiogenic intervention by developing therapeutic
strategies that precisely balance vessel regression and normali-
zation. On the one hand, tumor starvation needs to be promoted,
and on the other hand, drug delivery should be facilitated.
Toward this end anti-ANG2 treatments are in advanced clinical
development. Such treatments appear to be of limited efficacy
as monotherapy, but show improved efficacy in combination
with anti-VEGF/VEGFR regimens (Daly et al., 2013; Gerald
et al., 2013). Canonical WNT signaling has also been described
to induce vessel normalization by inducing pericyte recruitment
and may similarly be a promising target for future combination
therapies (Reis et al., 2012).
Role of Deregulated Vessel Pruning and Regression in
Disease Development
A number of diseases are directly or indirectly caused by per-
turbedmicrovascular remodeling and/or aberrant vessel pruning
and regression. Only some prominent examples can be dis-
cussed here. Notably, retinal hypovascularization diseases
such as diabetic retinopathy, age-related macular degeneration
(AMD), ROP, diabetic retinopathy (DR), Norrie disease (ND), fa-
milial exudative vitreoretinopathy (FEVR), and Coats disease
are the globally leading causes of blindness. These disorders
involve the failure of hyaloid vessel regression or reduced vascu-
larization of the retina, resulting in subsequent neovasculariza-
tion. Whereas the pathophysiology of these diseases is similar,
the underlying causes are different (Jager et al., 2008; Ye et al.,
2010). Vessel obliteration in ROP is induced by exposure ofDevelopmental Cell 34, July 6, 2015 ª2015 Elsevier Inc. 13
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velops as consequence of age-related defective retina vascular-
ization (Chen and Smith, 2007; Jager et al., 2008). Destruction of
retinal vessels in DR involves hyperglycemia, oxidative stress,
advanced glycation endproduct formation, and hemodynamic
changes (Tarr et al., 2013). In contrast, ND, FEVR, and Coats dis-
ease are hereditary disorders characterized by X-linked NDP
mutations and in the case of FEVR also autosomal FZD4,
LRP5, and TSPAN12mutations (Ye et al., 2010). Thus, mutations
in WNT signaling mediators are responsible for impaired retinal
vascularization, pointing to the importance of WNT signaling
for vessel stabilization.
Alzheimer’s disease involves brain hypoperfusion, which is
caused by vascular risk factors or cerebrovascular disorders
including stroke and ischemia, results in downregulation of
VEGF expression. Subsequent vessel regression induces hyp-
oxia and accumulation of neurotoxins including amyloid-b-pep-
tide, which form oligomers that are anti-angiogenic and cause
cerebral b-amyloidosis (Sagare et al., 2012). Perfusion deficits
also cause other neurodegenerative disorders by decreasing
VEGF expression (Quaegebeur et al., 2011). The involvement
of vessel pruning and regression in multiple diseases highlights
the importance of improving the mechanistic understanding of
these processes under physiological as well as pathological
conditions.
Future Perspective
Although morphological rearrangements during regressive
vessel remodeling as well as contributing signaling pathways
have been investigated to some extent, further research is
required to improve our understanding of physiological as
well as pathological vessel pruning and regression. Most
notably, the contribution of EC migration and apoptosis to
vessel pruning and regression in different vascular beds and
under different conditions needs further study. Does the
involvement of apoptosis in vessel regression depend on the
extent of vascular regression? Is apoptosis more prominent
in regression processes resulting in drastic reduction of
network complexity? Improved in vivo systems suitable for
high-resolution live imaging, taking the dynamics of the pruning
process into account, are required to unravel the fate of ECs
during vessel pruning and regression. The design of novel
techniques should particularly aim at deciphering the contri-
bution of EC proliferation/angiogenesis/maturation, vascular
constriction/dilation, and cellular extension/regression to the
remodeling process. The role of bystander cells including peri-
cytes, neural cells, and macrophages and signals provided by
these cells for controlling vessel remodeling are still terra
incognita and require further investigation. Although vessel
pruning and regression have been described in a multitude of
disease processes, the exact morphological rearrangements
and involved signaling pathways are still poorly understood.
Do physiological and pathological pruning and regression
follow the same mechanistic principles? Understanding the
contribution of EC migration, rearrangement, and survival to
vessel pruning and regression in the chaotropic tumor vascula-
ture is of particular importance to improve the efficacy of
anti-angiogenic therapy and other forms of angiomanipulatory
therapies.14 Developmental Cell 34, July 6, 2015 ª2015 Elsevier Inc.ACKNOWLEDGMENTS
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